Always consult with healthcare professionals or researchers for the latest information on the development and potential applications of tetrandrine in the context of the PI3K/AKT/mTOR pathway and cancer therapy (Kuo and Lin, 2003, Lee et al., 2010, Chen et al., 2014). The gene discussed is AKT1; the disease is cancer.